Comparison

KRAS Antibody (monoclonal) (M02)

Item no. ABC-AT2651a
Manufacturer Abcepta
Amount 100 ug
Category
Type Antibody Monoclonal
Format Liquid
Applications WB, ELISA
Clone 4F3
Specific against Human (Homo sapiens)
Host Mouse
Isotype IgG2a Kappa
Citations 1.Synergistic Effects of Combined Wnt/KRAS Inhibition in Colorectal Cancer Cells.Mologni L, Brussolo S, Ceccon M, Gambacorti-Passerini C.PLoS One. 2012;7(12):e51449. doi: 10.1371/journal.pone.0051449. Epub 2012 Dec 5.
NCBI NP_004976.2,NP_203524.1
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Alias GTPase KRas,K-Ras 2,Ki-Ras,c-K-ras,c-Ki-ras,GTPase KRas,N-terminally processed,KRAS,KRAS2,RASK2
Similar products KRAS, N-terminally processed, KRAS2, RASK2, GTPase KRas, K-Ras 2, Ki-Ras, c-K-ras, c-Ki-ras
Available
Manufacturer - Targets
KRAS (NP_004976, 16 a.a. ~ 125 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Bio Background
This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region.
Clonality
Monoclonal
Gene Name
KRAS
Subtitle
Mouse monoclonal antibody raised against a partial recombinant KRAS.
Reactivity
H
Formulation
Clear, colorless solution in phosphate buffered saline, pH 7.2 .
Concentration
1 mg/ml
Dilution
WB: 1:500~1000
WB: 1:500~1000
WB: 1:500~1000
E
Org Accession
NP_004976
Gene Description
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
Gene Summary
This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq
Antigen Type
Recombinant Protein

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close